Neutrophil extracellular traps can activate alternative complement pathways
Tóm tắt
The interaction between neutrophils and activation of alternative complement pathway plays a pivotal role in the pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). ANCAs activate primed neutrophils to release neutrophil extracellular traps (NETs), which have recently gathered increasing attention in the development of AAV. The relationship between NETs and alternative complement pathway has not been elucidated. The current study aimed to investigate the relationship between NETs and alternative complement pathway. Detection of components of alternative complement pathway on NETs in vitro was assessed by immunostain and confocal microscopy. Complement deposition on NETs were detected after incubation with magnesium salt ethyleneglycol tetraacetic acid (Mg-EGTA)-treated human serum. After incubation of serum with supernatants enriched in ANCA-induced NETs, levels of complement components in supernatants were measured by enzyme-linked immunosorbent assay (ELISA). Complement factor B (Bb) and properdin deposited on NETs in vitro. The deposition of C3b and C5b-9 on NETs incubated with heat-inactivated normal human serum (Hi-NHS) or EGTA-treated Hi-NHS (Mg-EGTA-Hi-NHS) were significantly less than that on NETs incubated with NHS or EGTA-treated NHS (Mg-EGTA-NHS). NETs induced by ANCA could activate the alternative complement cascade in the serum. In the presence of EGTA, C3a, C5a and SC5b-9 concentration decreased from 800·42 ± 244·81 ng/ml, 7·68 ± 1·50 ng/ml, 382·15 ± 159·75 ng/ml in the supernatants enriched in ANCA induced NETs to 479·07 ± 156·2 ng/ml, 4·86 ± 1·26 ng/ml, 212·65 ± 44·40 ng/ml in the supernatants of DNase I-degraded NETs (P < 0·001, P = 0·008, P < 0·001, respectively). NETs could activate the alternative complement pathway, and might thus participate in the pathogenesis of AAV.
Từ khóa
Tài liệu tham khảo
Jennette, 2013, 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides, Arthritis Rheum, 65, 1, 10.1002/art.37715
Chen, 2008, Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients, Medicine (Baltimore), 87, 203, 10.1097/MD.0b013e31817c744b
Falk, 1990, Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro, Proc Natl Acad Sci USA, 87, 4115, 10.1073/pnas.87.11.4115
Kessenbrock, 2009, Netting neutrophils in autoimmune small-vessel vasculitis, Nat Med, 15, 623, 10.1038/nm.1959
Lande, 2007, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide, Nature, 449, 564, 10.1038/nature06116
Sangaletti, 2012, Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity, Blood, 120, 3007, 10.1182/blood-2012-03-416156
Xing, 2010, Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis, J Clin Immunol, 30, 144, 10.1007/s10875-009-9344-2
Xiao, 2007, Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies, Am J Pathol, 170, 52, 10.2353/ajpath.2007.060573
Gou, 2013, Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis, Kidney Int, 83, 129, 10.1038/ki.2012.313
Xing, 2009, Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis, J Clin Immunol, 29, 282, 10.1007/s10875-008-9268-2
Huugen, 2007, Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice, Kidney Int, 71, 646, 10.1038/sj.ki.5002103
Leffler, 2012, Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease, J Immunol, 188, 3522, 10.4049/jimmunol.1102404
Chen, 2010, The complement system in systemic autoimmune disease, J Autoimmun, 34, J276, 10.1016/j.jaut.2009.11.014
Van Timmeren, 2009, Review article: pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis, Nephrology (Carlton), 14, 16, 10.1111/j.1440-1797.2009.01086.x
Schreiber, 2010, Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis, Kidney Int, 77, 118, 10.1038/ki.2009.420
Choi, 2003, Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA, Kidney Int, 63, 96, 10.1046/j.1523-1755.2003.00718.x
Aga, 2002, Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major, J Immunol, 169, 898, 10.4049/jimmunol.169.2.898
Jiang, 2004, Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies, Mol Ther, 10, 1140, 10.1016/j.ymthe.2004.08.015
Nakao, 2004, A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface, Fish Shellfish Immunol, 16, 139, 10.1016/S1050-4648(03)00057-3
Nakazawa, 2012, Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 64, 3779, 10.1002/art.34619
Saffarzadeh, 2012, Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones, PLOS ONE, 7, e32366, 10.1371/journal.pone.0032366
Mershon-Shier, 2011, In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways, Mol Immunol, 48, 2009, 10.1016/j.molimm.2011.06.215
Sahu, 2001, Structure and biology of complement protein C3, a connecting link between innate and acquired immunity, Immunol Rev, 180, 35, 10.1034/j.1600-065X.2001.1800103.x
Nakazawa, 2014, Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis, J Am Soc Nephrol, 25, 990, 10.1681/ASN.2013060606
Nakazawa, 2012, Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 64, 3779, 10.1002/art.34619
Camous, 2011, Complement alternative pathway acts as a positive feedback amplification of neutrophil activation, Blood, 117, 1340, 10.1182/blood-2010-05-283564
Wirthmueller, 1997, Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils, J Immunol, 158, 4444, 10.4049/jimmunol.158.9.4444
Schreiber, 2009, C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis, J Am Soc Nephrol, 20, 289, 10.1681/ASN.2008050497
Huber-Lang, 2002, Generation of C5a by phagocytic cells, Am J Pathol, 161, 1849, 10.1016/S0002-9440(10)64461-6
Chen, 2009, Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis, Nephrol Dial Transplant, 24, 1247, 10.1093/ndt/gfn586
Hao, 2012, p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation, PLOS ONE, 7, e38317, 10.1371/journal.pone.0038317
Kambas, 2014, Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease, Ann Rheum Dis, 73, 1854, 10.1136/annrheumdis-2013-203430
Huber-Lang, 2006, Generation of C5a in the absence of C3: a new complement activation pathway, Nat Med, 12, 682, 10.1038/nm1419
Krisinger, 2012, Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway, Blood, 120, 1717, 10.1182/blood-2012-02-412080